Sinopharm Group (Germany) Price on April 17, 2024
| X2S Stock | EUR 2.68 0.02 0.75% |
If you're considering investing in Sinopharm Stock, it is important to understand the factors that can impact its price. As of today, the current price of Sinopharm Group stands at 2.68, as last reported on the 29th of December, with the highest price reaching 2.68 and the lowest price hitting 2.68 during the day. Sinopharm Group appears to be unstable, given 3 months investment horizon. Sinopharm Group owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0841, which indicates the firm had a 0.0841% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Sinopharm Group Co, which you can use to evaluate the volatility of the company. Please review Sinopharm Group's Coefficient Of Variation of 585.37, semi deviation of 2.28, and Risk Adjusted Performance of 0.1432 to confirm if our risk estimates are consistent with your expectations.
Sinopharm Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Sinopharm |
Sharpe Ratio = 0.0841
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | X2S | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.44 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.21 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Sinopharm Group is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sinopharm Group by adding it to a well-diversified portfolio.
Sinopharm Group Valuation on April 17, 2024
It is possible to determine the worth of Sinopharm Group on a given historical date. On April 17, 2024 Sinopharm was worth 1.49 at the beginning of the trading date compared to the closed value of 1.49. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sinopharm Group stock. Still, in general, we apply an absolute valuation method to find Sinopharm Group's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sinopharm Group where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sinopharm Group's related companies.
| Open | High | Low | Close | Volume | |
| 1.47 | 1.47 | 1.44 | 1.47 | 1.00 | |
04/17/2024 | 1.49 | 1.49 | 1.49 | 1.49 | 13,992 |
| 1.49 | 1.49 | 1.49 | 1.49 | 1.00 |
| Backtest Sinopharm Group | | | Sinopharm Group History | | | Sinopharm Group Valuation | Previous | Next |
Sinopharm Group Trading Date Momentum on April 17, 2024
| On April 18 2024 Sinopharm Group Co was traded for 1.49 at the closing time. The highest daily price throughout the period was 1.49 and the lowest price was 1.49 . There was no trading activity during the period 1.0. Lack of trading volume on 04/18/2024 did not result in any price rise and fall. The trading price change to current closing price is 1.34% . |
Sinopharm Group Fundamentals Correlations and Trends
By evaluating Sinopharm Group's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sinopharm Group's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Sinopharm financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Sinopharm Group Stock history
Sinopharm Group investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Sinopharm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sinopharm Group will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sinopharm Group stock prices may prove useful in developing a viable investing in Sinopharm Group
Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the Peoples Republic of China. The company was founded in 2003 and is headquartered in Shanghai, the Peoples Republic of China. SINOPHARM GRP operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 108370 people.
Sinopharm Group Stock Technical Analysis
Sinopharm Group technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Sinopharm Group Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
Sinopharm Group Co cannot be verified against its exchange. Please verify the symbol is currently traded on Frankfurt Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Sinopharm Group December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Sinopharm Group stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sinopharm Group shares will generate the highest return on investment. By undertsting and applying Sinopharm Group stock market strength indicators, traders can identify Sinopharm Group Co entry and exit signals to maximize returns
Sinopharm Group Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Sinopharm Group's price direction in advance. Along with the technical and fundamental analysis of Sinopharm Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Sinopharm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1432 | |||
| Jensen Alpha | 0.4476 | |||
| Total Risk Alpha | 0.3727 | |||
| Sortino Ratio | 0.144 | |||
| Treynor Ratio | (21.09) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Sinopharm Stock analysis
When running Sinopharm Group's price analysis, check to measure Sinopharm Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinopharm Group is operating at the current time. Most of Sinopharm Group's value examination focuses on studying past and present price action to predict the probability of Sinopharm Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinopharm Group's price. Additionally, you may evaluate how the addition of Sinopharm Group to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |